| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.11B | 69.87B | 65.19B | 58.14B | 55.93B | 60.04B |
| Gross Profit | 21.86B | 20.97B | 19.38B | 18.01B | 17.00B | 17.34B |
| EBITDA | 7.14B | 6.89B | 5.11B | 4.37B | 3.86B | 3.54B |
| Net Income | 4.74B | 4.60B | 3.19B | 2.68B | 2.25B | 1.93B |
Balance Sheet | ||||||
| Total Assets | 43.39B | 44.47B | 37.21B | 35.95B | 33.26B | 34.75B |
| Cash, Cash Equivalents and Short-Term Investments | 16.86B | 17.78B | 9.90B | 10.65B | 12.11B | 10.75B |
| Total Debt | 2.59B | 2.69B | 102.00M | 213.00M | 596.00M | 875.00M |
| Total Liabilities | 19.04B | 20.28B | 16.03B | 16.07B | 15.24B | 17.14B |
| Stockholders Equity | 24.35B | 24.18B | 21.18B | 19.88B | 18.02B | 17.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.61B | 1.13B | 129.00M | 3.34B | 2.30B |
| Operating Cash Flow | 0.00 | 6.64B | 1.24B | 910.00M | 3.56B | 2.55B |
| Investing Cash Flow | 0.00 | 361.00M | 393.00M | -964.00M | -67.00M | -197.00M |
| Financing Cash Flow | 0.00 | 886.00M | -2.42B | -1.39B | -2.14B | -1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥87.55B | 19.07 | ― | 2.32% | 5.09% | 26.12% | |
77 Outperform | ¥72.43B | 7.46 | ― | 3.28% | 5.28% | 28.90% | |
76 Outperform | ¥152.20B | 14.81 | ― | 2.30% | 13.82% | 37.07% | |
75 Outperform | ¥145.02B | 9.34 | 11.52% | 2.76% | 4.00% | 38.72% | |
74 Outperform | ¥267.54B | 28.54 | ― | 0.22% | 25.00% | 62.07% | |
65 Neutral | ¥30.51B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |